Sustained release composition of prostacyclin

US9872864B2 · kind B2 · utility

Assignee

• ASCENDIS PHARMA A/S · DK

Inventors

• Kennett Sprogøe · Rudegård, DK
• Harald Rau · Würzburg, DE
• Ulrich Hersel · Heidelberg, DE
• Thomas Wegge · Heidelberg, DE
• Oliver Keil · Glienicke, DE
• Joachim Zettler · Heidelberg, DE

Key dates

• Filing date: Aug 10, 2012
• Grant date: Jan 23, 2018
• Expiry date: Aug 10, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to sustained release compositions of prostacyclin, as well as uses thereof, in particular for the prevention and/or treatment of pulmonary arterial hypertension.